These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 624694)

  • 21. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN; Bollinger M
    Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.
    Bergeron MG; Nguyen BM; Trottier S; Gauvreau L
    Antimicrob Agents Chemother; 1977 Dec; 12(6):682-7. PubMed ID: 931366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antimicrobial activity of cefamandole.
    Meyers BR
    Scand J Infect Dis Suppl; 1980; suppl 25():17-22. PubMed ID: 6937948
    [No Abstract]   [Full Text] [Related]  

  • 30. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 33. Cephalothin and cefamandole penetration into bone, synovial fluid, and wound drainage fluid.
    Schurman DJ; Hirshman HP; Burton DS
    J Bone Joint Surg Am; 1980 Sep; 62(6):981-5. PubMed ID: 7430187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R; Schröter G
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
    Thabaut A; Durosoir JL; Saliou P
    Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the in vitro activity of cephalothin and cefamandole on methillicin-resistant strains of Staphylococcus aureus and epidermidis].
    Bianchi P; Caroppo BG; Pasticci MB; Galuppo L; Frongillo RF
    Clin Ter; 1984 Feb; 108(4):283-9. PubMed ID: 6232064
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 38. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Various pharmacological and clinical aspects of 1st-, 2d- and 3d-generation cephalosporins (I)].
    Barucchi AM; Mazza A; Pesce A; Viti M
    Parodontol Stomatol (Nuova); 1985; 24(1):119-31. PubMed ID: 3937980
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.